Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D01JGD
|
||||
Former ID |
DIB001844
|
||||
Drug Name |
AD-03
|
||||
Synonyms |
AFFITOPE AD03; Amyloid beta vaccine (Affitome, Alzheimers disease), AFFiRiS/ GlaxoSmithKline
|
||||
Drug Type |
Vaccine
|
||||
Indication | Alzheimer disease [ICD9: 331; ICD10:G30] | Phase 1 | [1] | ||
Company |
AFFiRiS AG
|
||||
Target and Pathway | |||||
Target(s) | Amyloid beta A4 protein | Target Info | [2] | ||
KEGG Pathway | Notch signaling pathway | ||||
Alzheimer's disease | |||||
Reactome | Nuclear signaling by ERBB4 | ||||
Degradation of the extracellular matrix | |||||
Regulated proteolysis of p75NTR | |||||
NRIF signals cell death from the nucleus | |||||
Activated NOTCH1 Transmits Signal to the Nucleus | |||||
Constitutive Signaling by NOTCH1 PEST Domain Mutants | |||||
Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | |||||
EPH-ephrin mediated repulsion of cells | |||||
WikiPathways | Notch Signaling Pathway | ||||
Signaling by ERBB4 | |||||
Signaling by NOTCH3 | |||||
Signaling by NOTCH4 | |||||
Signaling by NOTCH1 | |||||
Signaling by NOTCH2 | |||||
Notch Signaling Pathway | |||||
Alzheimers Disease | |||||
Signalling by NGF | |||||
References | |||||
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800033932) | ||||
REF 2 | Disease-modifying drugs in Alzheimer's disease. Drug Des Devel Ther. 2013; 7: 1471-1479. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.